World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
48
Citations
13575
World Ranking
18222
National Ranking
581

Luisa Lanfrancone publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Luisa Lanfrancone sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 134 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Luisa Lanfrancone D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Luisa Lanfrancone sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 48 D-Index — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Luisa Lanfrancone is affiliated with the European Institute of Oncology in Italy and has an extensive publication record primarily focused on biochemistry, genetics, molecular biology, and medicine. Their research spans multiple subfields including molecular biology, oncology, cancer research, immunology, and biophysics.

Their recent research output includes notable papers published between 2021 and 2023, featuring topics related to cancer biology, melanoma, and molecular pathways. Selected recent papers include:

  • TFEB and TFE3 drive kidney cystogenesis and tumorigenesis, 2023, EMBO Molecular Medicine
  • Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process, 2022, Cells
  • Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors, 2022, Cell Reports
  • Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation, 2021, EMBO Reports
  • Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma, 2022, Cell Reports

Their work addresses several main topics, such as:

  • Melanoma and MAPK Pathways
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Epigenetics and DNA Methylation
  • Immunotherapy and Immune Responses
  • RNA Research and Splicing
  • Cancer Cells and Metastasis

The frequent coauthors who have collaborated with Luisa Lanfrancone include:

  • Federica Marocchi
  • Pier Giuseppe Pelicci
  • Daniela Bossi
  • Pier Francesco Ferrucci
  • Fiorenza Lotti

Lanfrancone's publications are often found in journals with a focus on translational and molecular research. The most frequent publication venues include:

  • Journal of Translational Medicine
  • Cancer Research
  • Cell Reports
  • EMBO Reports
  • Nature Communications

The scientist's body of work covers a significant number of publications with an emphasis on the molecular mechanisms underlying cancer progression, therapeutic resistance, and biomarker identification. Their research contributions support broader efforts in understanding melanoma biology and developing potential diagnostic and treatment strategies in oncology.

Best Publications

  • The p66shc adaptor protein controls oxidative stress response and life span in mammals

    Enrica Migliaccio;Marco Giorgio;Simonetta Mele;Giuliana Pelicci

  • A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

    Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

  • Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Annette T. Byrne;Denis G. Alférez;Frédéric Amant;Daniela Annibali

  • Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells.

    Fabio Re;Adriana Zanetti;Marina Sironi;Nadia Polentarutti

  • A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis.

    Mirella Trinei;Marco Giorgio;Angelo Cicalese;Sara Barozzi

  • Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

    Enrica Migliaccio;Simonetta Mele;Anna E. Salcini;Giuliana Pelicci

  • High-Efficiency Gene Transfer and Selection of Human Hematopoietic Progenitor Cells with a Hybrid EBV/Retroviral Vector Expressing the Green Fluorescence Protein

    Francesco Grignani;Todd Kinsella;Amedea Mencarelli;Mauro Valtieri

  • The Life Span Determinant p66Shc Localizes to Mitochondria Where It Associates with Mitochondrial Heat Shock Protein 70 and Regulates Trans-membrane Potential

    Francesca Orsini;Enrica Migliaccio;Maurizio Moroni;Cristina Contursi

  • Not all Shc's roads lead to Ras

    Laura Bonfini;Enrica Migliaccio;Giuliana Pelicci;Luisa Lanfrancone

  • Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells.

    Nives Jonjić;Giuseppe Peri;Sergio Bernasconi;Francesca Luisa Sciacca

  • Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc

    Stephen M. Dilworth;Charlotte E. P. Brewster;Michael D. Jones;Luisa Lanfrancone

  • The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein

    G Pelicci;Silvia Giordano;Z Zhen;Ae Salcini

  • Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

    Mohamed Elgendy;Marco Cirò;Amir Hosseini;Jakob Weiszmann

  • Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1.

    L Lanfrancone;D Boraschi;P Ghiara;B Falini

  • Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia

    Pier Giuseppe Pelicci;Luisa Lanfrancone;Michel D. Brathwaite;Sandra R. Wolman

  • A New Variant Anaplastic Lymphoma Kinase (ALK)-Fusion Protein (ATIC-ALK) in a Case of ALK-positive Anaplastic Large Cell Lymphoma

    Mirella Trinei;Luisa Lanfrancone;Elias Campo;Karen Pulford

  • Tbx3 Represses E-Cadherin Expression and Enhances Melanoma Invasiveness

    Mercedes Rodriguez;Ewa Aladowicz;Luisa Lanfrancone;Colin R. Goding

  • Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth.

    Chiara Di Malta;Diletta Siciliano;Alessia Calcagni;Jlenia Monfregola

  • Expression of Adhesion Molecules and Chemotactic Cytokines in Cultured Human Mesothelial Cells By Nives Jonji6,* Giuseppe Peri,* Sergio Bernasconi,*

    Francesca Luisa Sciacca;Francesco Colotta;PierGiuseppe Pelicci;Luisa Lanfrancone

  • splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway

    Enrica Migliaccio;Simonetta Mele;Giuliana Pelicci;Tony Pawson

Frequent Co-Authors

Pier Giuseppe Pelicci
Pier Giuseppe Pelicci European Institute of Oncology
Saverio Minucci
Saverio Minucci European Institute of Oncology
Cosima T. Baldari
Cosima T. Baldari University of Siena
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Tony Pawson
Tony Pawson University of Toronto
Enzo Medico
Enzo Medico University of Turin
Gioacchino Natoli
Gioacchino Natoli European Institute of Oncology
Giulio Draetta
Giulio Draetta The University of Texas MD Anderson Cancer Center
Myriam Alcalay
Myriam Alcalay University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens doors to diverse online degree opportunities and fast-growing careers in healthcare, research, and management. If you’re passionate about nutrition and wellness, consider pursuing a nutritionist degree online. This pathway prepares graduates for roles in dietary planning, education, and nutritional counseling.

For those interested in healthcare leadership, exploring top cahme-accredited mha programs can lead to advanced management positions within hospitals, clinics, and health systems. These programs balance healthcare knowledge with essential business skills.

If you are a registered nurse aiming for top clinical or leadership roles without direct patient care requirements, look into online dnp programs without clinicals. These doctorates typically emphasize policy, research, and advanced healthcare administration.

Finally, a phd in healthcare management online is ideal for aspiring executives and academics who want to drive change in healthcare policy, operations, or research. These programs offer flexibility for working professionals seeking higher-level opportunities.

Best Scientists Citing Luisa Lanfrancone

Trending Scientists

Recently Published Articles